These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11940319)

  • 21. [Advanced oxidation protein products in diabetic nephropathy patients and its relation with superoxide dismutase, glutathione peroxidase, neopterin].
    Wu ZX; Xue YM; Li CZ; Guan MP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):704-7. PubMed ID: 16708815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL).
    Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.
    Ikeda Y; Suehiro T; Inoue M; Nakauchi Y; Morita T; Arii K; Ito H; Kumon Y; Hashimoto K
    Metabolism; 1998 May; 47(5):598-602. PubMed ID: 9591753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum paraoxonase levels in gastric cancer.
    Akçay MN; Yilmaz I; Polat MF; Akçay G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxiii-cclxxv. PubMed ID: 15244199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
    Mastorikou M; Mackness M; Mackness B
    Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein.
    Lakshmy R; Ahmad D; Abraham RA; Sharma M; Vemparala K; Das S; Reddy KS; Prabhakaran D
    Indian J Med Res; 2010 Apr; 131():522-9. PubMed ID: 20424303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous L-arginine and HDL can alter LDL and ox-LDL-mediated platelet activation: using platelet P-selectin receptor numbers.
    Sener A; Enc E; Ozsavci D; Vanizor-Kural B; Yanikkaya-Demirel G; Oba R; Uras F; Demir M
    Clin Appl Thromb Hemost; 2011; 17(6):E79-86. PubMed ID: 21078607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy.
    Wang F; Xing T; Wang N; Liu L
    Cytokine; 2012 Jan; 57(1):127-9. PubMed ID: 22088599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
    Sözmen EY; Sözmen B; Delen Y; Onat T
    Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
    Kordonouri O; James RW; Bennetts B; Chan A; Kao YL; Danne T; Silink M; Donaghue K
    Metabolism; 2001 Jun; 50(6):657-60. PubMed ID: 11398141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum paraoxonase levels in pancreatic cancer.
    Akçay MN; Polat MF; Yilmaz I; Akçay G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxv-ccxxvii. PubMed ID: 15244186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between platelet hyperactivation and dyslipoproteinemia in diabetic nephropathy].
    Tóth L; Szénási P; Varsányi-Nagy M; Szilvási I; Vörös P; Romics L; Kammerer L
    Orv Hetil; 1992 Apr; 133(17):1037-40. PubMed ID: 1579341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biomarkers of endothelial dysfunction and risk of early organ damage: a comparison between patients with primary aldosteronism and essential hypertension].
    Liu G; Zhang SL; Liu PM; Yin GS; Tang JY; Ma DJ; Yan L; Wang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):640-4. PubMed ID: 23141006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: role of biomarkers.
    Kanbak G; Akalin A; Dokumacioglu A; Ozcelik E; Bal C
    Diabetes Metab Syndr; 2011; 5(1):7-11. PubMed ID: 22814834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between oxidized low-density lipoprotein and other factors in patients on peritoneal dialysis.
    Futatsuyama M; Oiwa T; Komatsu Y
    Adv Perit Dial; 2002; 18():192-4. PubMed ID: 12402617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy.
    Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y
    Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors.
    Koubaa N; Nakbi A; Smaoui M; Abid N; Chaaba R; Abid M; Hammami M
    Clin Biochem; 2007 Sep; 40(13-14):1007-14. PubMed ID: 17618615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
    Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.